Core Laboratories Inc (MEX:CLB)
MXN 856.38 (0%) Market Cap: 10.48 Bil Enterprise Value: 13.09 Bil PE Ratio: 17.50 PB Ratio: 1.98 GF Score: 62/100

Q2 2025 Core Laboratories Inc Earnings Call Transcript

Jul 24, 2025 / 12:30PM GMT
Release Date Price: MXN856.38

Key Points

Positve
  • Core Laboratories Inc (CLB) reported a 5% increase in revenue for Q2 2025 compared to Q1, indicating positive growth momentum.
  • The company achieved sequential improvement in operating income, operating margins, free cash flow, and earnings per share.
  • Core Laboratories Inc (CLB) reduced its net debt by more than $9 million, achieving its lowest leverage ratio in eight years at 1.27.
  • The company successfully repurchased over 237,000 shares, returning $2.7 million to shareholders, aligning with its strategy to enhance shareholder value.
  • Core Laboratories Inc (CLB) continues to expand its innovative offerings, such as the HERO PerFRAC perforating system and thermal profiler tracers, which have shown strong performance and market acceptance.
Negative
  • The demand for laboratory services tied to the assay of crude oil remains uncertain due to ongoing geopolitical conflicts and sanctions.
  • There was a sequential decrease in diagnostic services after a five-year high in the first quarter, impacting growth expectations.
  • The company faces challenges from elevated tariffs, which have increased costs despite improved manufacturing efficiencies.
  • US onshore activity levels are sensitive to crude oil price volatility, which could impact short-term revenue from this segment.
  • The success rates in drilling international and offshore exploration wells have decreased, negatively affecting anticipated growth in reservoir rock and fluid analytical programs.
Operator

Good day, and welcome to the Core Laboratories Q2 2025 earnings call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Larry Bruno, President. Please go ahead.

Lawrence Bruno
Core Laboratories Inc - Chairman of the Board, President, Chief Executive Officer

Thanks, Keith. Good morning in the Americas, good afternoon in Europe, Africa and the Middle East, and good evening in evening in Asia Pacific. We'd like to welcome all of our shareholders, analysts and most importantly, our employees to Core Laboratories second quarter 2025 earnings call. This morning, I'm joined by Chris Hill, Core's Chief Financial Officer; and Gwen Gresham, Core's Senior Vice President and Head of Investor Relations. The call will be divided into six segments.

Gwen will start by making remarks regarding forward-looking statements. We'll then have some opening comments, including a high-level review of important factors in Core's Q2 performance. In addition, we'll review Core's strategies and the three

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot